{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T08:09:48.025242+00:00","published_at":"2026-10-17T04:47:15.429264+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1fj8i1t1w968hb","event_type":"CFO_CHANGED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:dan-conn-j-d-m-b-a","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:a3be88b5fda3feda2f2c9ae40f045f30f4356a209fc3c546dee8bb94cfada7d3"],"summary":"Dan Conn, J.D., M.B.A. executive of Tvardi Therapeutics, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:u7tbr9iqqdax","event_type":"CEO_CHANGED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:imran-alibhai-ph-d","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:f12493987f012e34ae11cd13d135857314e7d4f516ec7cc1c8f65a153d3d9900"],"summary":"Imran Alibhai, Ph.D. executive of Tvardi Therapeutics, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:xed3te1x98wkk","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:john-kauh-m-d","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:f702ccbe4cb1393128ecdc54cfb32376782fb1f30af57929af598665f13a5b3b"],"summary":"John Kauh, M.D. executive of Tvardi Therapeutics, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16lx2yhsx7gpr","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:cynthia-smith","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Cynthia Smith seat on Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1r6fz8ze6qh4","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:imran-alibhai-ph-d","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Imran Alibhai, Ph.D. seat on Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:frnipv176nz0l","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:michael-s-wyzga","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Michael S. Wyzga seat on Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1q0zc461ppwcjy","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:sujal-shah","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Sujal Shah seat on Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2shl9h98rqu3","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:susan-shiff-ph-d","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Susan Shiff, Ph.D. seat on Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1jzqa7jefvqtr","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:wallace-l-hall-jr","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Wallace L. Hall, Jr. seat on Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1lse33jnr9srx","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:committee:tvardi-therapeutics-inc:audit-chair","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Audit · Chair committee of Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:126g86is21m9w","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:michael-s-wyzga","alpha:committee:tvardi-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Michael S. Wyzga member of Audit · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1gd5iebugvlzj","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:committee:tvardi-therapeutics-inc:audit-compensation","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Audit; Compensation committee of Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:bpsijp1v4pjj3","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:wallace-l-hall-jr","alpha:committee:tvardi-therapeutics-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Wallace L. Hall, Jr. member of Audit; Compensation, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nqgoj2blrwqu","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:committee:tvardi-therapeutics-inc:compensation-chair","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Compensation · Chair committee of Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:6vgg72z9yy6","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:sujal-shah","alpha:committee:tvardi-therapeutics-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Sujal Shah member of Compensation · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1pr9k2d1k9ycvb","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:committee:tvardi-therapeutics-inc:nominating-and-governance-chair","alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Nominating and Governance · Chair committee of Tvardi Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:xet330y52r0c","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:47:15.429264+00:00","subject_ids":["alpha:person:cynthia-smith","alpha:committee:tvardi-therapeutics-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003"],"summary":"Cynthia Smith member of Nominating and Governance · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:5","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:cynthia-smith","object_label":"Cynthia Smith","object_source_name_forms":[],"value":"Cynthia Smith: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:cynthia-smith","name":"Cynthia Smith"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tvardi Therapeutics, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-25T00:17:01.093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:6","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:imran-alibhai-ph-d","object_label":"Imran Alibhai, Ph.D.","object_source_name_forms":[],"value":"Imran Alibhai, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:imran-alibhai-ph-d","name":"Imran Alibhai, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tvardi Therapeutics, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-25T00:17:01.093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:7","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-s-wyzga","object_label":"Michael S. Wyzga","object_source_name_forms":[],"value":"Michael S. Wyzga: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-s-wyzga","name":"Michael S. Wyzga"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tvardi Therapeutics, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-25T00:17:01.093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:8","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sujal-shah","object_label":"Sujal Shah","object_source_name_forms":[],"value":"Sujal Shah: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sujal-shah","name":"Sujal Shah"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tvardi Therapeutics, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-25T00:17:01.093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:9","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:susan-shiff-ph-d","object_label":"Susan Shiff, Ph.D.","object_source_name_forms":[],"value":"Susan Shiff, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:susan-shiff-ph-d","name":"Susan Shiff, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tvardi Therapeutics, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-25T00:17:01.093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:10","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:wallace-l-hall-jr","object_label":"Wallace L. Hall, Jr.","object_source_name_forms":[],"value":"Wallace L. Hall, Jr.: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:wallace-l-hall-jr","name":"Wallace L. Hall, Jr."},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tvardi Therapeutics, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-25T00:17:01.093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:11","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:dan-conn-j-d-m-b-a","object_label":"Dan Conn, J.D., M.B.A.","object_source_name_forms":[],"value":"Dan Conn, J.D., M.B.A.: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:dan-conn-j-d-m-b-a","name":"Dan Conn, J.D., M.B.A."},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:a3be88b5fda3feda2f2c9ae40f045f30f4356a209fc3c546dee8bb94cfada7d3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TVRD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T09:24:49.609721+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:12","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:imran-alibhai-ph-d","object_label":"Imran Alibhai, Ph.D.","object_source_name_forms":[],"value":"Imran Alibhai, Ph.D.: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:imran-alibhai-ph-d","name":"Imran Alibhai, Ph.D."},"title":"Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:f12493987f012e34ae11cd13d135857314e7d4f516ec7cc1c8f65a153d3d9900","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TVRD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T09:24:49.103869+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:13","subject_id":"alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-kauh-m-d","object_label":"John Kauh, M.D.","object_source_name_forms":[],"value":"John Kauh, M.D.: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-kauh-m-d","name":"John Kauh, M.D."},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:47:15.429264+00:00","sources":[{"id":"alpha:projection-evidence:document:f702ccbe4cb1393128ecdc54cfb32376782fb1f30af57929af598665f13a5b3b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TVRD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T09:24:50.075713+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tvardi Therapeutics, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-25T00:17:01.093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a3be88b5fda3feda2f2c9ae40f045f30f4356a209fc3c546dee8bb94cfada7d3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TVRD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T09:24:49.609721+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f12493987f012e34ae11cd13d135857314e7d4f516ec7cc1c8f65a153d3d9900","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TVRD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T09:24:49.103869+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f702ccbe4cb1393128ecdc54cfb32376782fb1f30af57929af598665f13a5b3b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TVRD DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T09:24:50.075713+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.839,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.876,"cross_source_agreement":0.75,"temporal_completeness":0.643},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:47:15.429264+00:00","observed_at":"2026-10-17T04:47:15.429264+00:00","reviewed_at":"2026-10-17T04:47:15.429264+00:00","verified_at":"2026-10-17T04:47:15.429264+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/tvardi-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}